Abstract
Our understanding of the clinical and pathological features of dementia in late life is changing. Indeed, the way we conceptualize, investigate, and manage dementia has altered radically over recent times. An increasing public awareness, coupled with greater expectations, changing demography, and an ever more productive research alliance among specialist clinicians, the scientific community, and the pharmacological industry are all influencing clinical practice. This is particularly true for dementia with Lewy bodies (DLB).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
